Home > Healthcare > Medical Devices > Therapeutic Devices > Microcatheters Market

Microcatheters Market Share

Report ID: GMI3572
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Microcatheters Market Share

The market is characterized by the presence of several prominent players, each striving to enhance their market share through product innovation, strategic acquisitions, and collaborations. Companies such as Stryker Corporation, Boston Scientific Corporation, and Medtronic hold significant shares in the market due to their comprehensive portfolios of microcatheters and strong global distribution networks.

These companies focus on developing advanced microcatheter technologies that offer improved navigation, flexibility, and safety, catering to the growing demand for minimally invasive procedures. The competitive landscape is further shaped by continuous research and development efforts, strategic partnerships, and the expansion of product lines. As a result, the market is expected to see increased consolidation, with key players strengthening their positions and smaller companies seeking to carve out niches in specialized areas.

Microcatheters Market Companies

Prominent players operating in the Microcatheters industry include:

Acrostak
Asahi Intecc USA, Inc (Asahi Intec co. ltd.)
Boston Scientific Corporation
Cardiovascular Systems, Inc (Abbott Laboratories, Inc.)
Cook Medical
Embolx, Inc.
Integer Holdings Corporation
Medtronic plc
Merit Medical System, Inc.
Penumbra, Inc.
Reflow Medical, Inc.
Stryker Corporation
Teleflex Corporation
Terumo Corporation
Transit Scientific

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The microcatheters industry size was valued at USD 985.5 million in 2023 and is expected to exhibit 5.1% CAGR from 2024

The steerable microcatheter industry size is expected to 5.3% CAGR through 2032 owing to enhanced success rates and reduced procedural time as compared to standard microcatheters.

The microcatheters market from the hospitals & clinics end-use segment is anticipated to reach USD 985.2 million by 2032 as they are typically well-equipped with advanced medical infrastructure.

North America microcatheters industry accounted for USD 331.4 million in revenue in 2023 owing to the growing prevalence of neurovascular and cardiovascular diseases, along with the increasing number of percutaneous coronary intervention procedures in the region.